IL6 and cancer: Thus, the over-secretion of IL-6 in TME, not only by the tumor cells themselves [53] but also by cancer-associated macrophages [54], fibroblasts [53], adipocytes [55], or mesenchymal stem cells [56], creates favorable conditions for tumor development and metastasis.